Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
一项针对转移性或不可切除实体瘤成年患者的单药 NIZ985(一种重组异二聚体 IL-15 激动剂)的 I 期研究
期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2021-003388
Conlon, Kevin; Watson, Dionysios C; Waldmann, Thomas A; Valentin, Antonio; Bergamaschi, Cristina; Felber, Barbara K; Peer, Cody J; Figg, William D; Potter, E Lake; Roederer, Mario; McNeel, Douglas G; Thompson, John A; Gupta, Sumati; Leidner, Rom; Wang-Gillam, Andrea; Parikh, Nehal S; Long, Debby; Kurtulus, Sema; Ho Lee, Lang; Chowdhury, Niladri Roy; Bender, Florent; Pavlakis, George N